Rosebud Biosciences

Growing micro-organs to find new drugs

EarlyY Combinator

Public description

Company overview

Growing micro-organs to find new drugs Website: https://rosebudbiosciences.com/ Source: Y Combinator

Named financing

Ownership and financing

Stage: Early Named backer: Y Combinator

Y Combinator

Company overview

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models. Batch: Winter 2022. Status: Active. Industry: Healthcare. Location: San Francisco, CA, USA; San Carlos, CA, USA

  • Rosebud Biosciences

    Company · Subject

  • Y Combinator

    LegalEntity · Named backer

Backer

Y Combinator

United States · United Kingdom

Y Combinator created a new model for funding early stage startups. Four times a year we invest in a large number of startups. The Collison brothers did YC twice—first in W07 and then in S09, when they started Stripe. [1] “ A formidable person is one who seems like they ’ ll get what they want, regardless of whatever obstacles are in the way. ” — Paul Graham During YC Sam was part of YC's inaugural batch in S05 and founded OpenAI as YC Research in 2015. In 2005, Y Combinator developed a new model of startup funding. Four times a year we invest $500k in a select group of startups. They move to San Francisco for three months, where we work intensively with them to get the company into the best possible shape, before they present to a large audience of investors on Demo Day. But YC doesn ’ t end on Demo Day. We and the YC alumni network continue to help founders for the life of their company, and beyond. Co-founder of Posterous (acquired by Twitter) and Initialized Capital. Early engineer at Palantir, designed company logo. Co-founder and CEO of Triplebyte (acquired by Karat) and Auctomatic (acquired by Live Current Media). Graduated from Oxford. Co-founder of Creative Market, generating over $100M in sales for independent creators worldwide. Co-founder and CTO of Escher Reality (acquired by Niantic). Shipped AR tech for Pokémon GO to 100M+ users and grew up in Chile. Led Growth at Airbnb for 4.5 years. Co-founder of Heysan. Previously Head of Growth at Voxer. Co-founder of Algol

Firm site